Rubicon Technologies Announces Completion of Final Key Strategic Finance Objective
Rubicon Technologies Announces Completion of Final Key Strategic Finance Objective
Entries by reedland
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilities
Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that it has entered into convertible note and loan financing facilities for up to $48.5 million with affiliates of Marathon Asset Management L.P. (Marathon) and SWK Holdings Corporation (Nasdaq: SWKH), subject to certain conditions. Proceeds from these financings would be used to advance Acer’s pipeline.
Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer
Agreement aims to accelerate development of a unique testosterone treatment for inflammatory breast diseases and estrogen-receptor positive breast cancer
Encina Business Credit Provides $60MM Facility to Provider of Waste Management Solutions
Chicago, IL – December 20, 2018 – Encina Business Credit, LLC (EBC) announced today that it has provided a $60 million senior secured credit facility to a provider of waste management solutions. The credit facility consists of a revolver secured by accounts receivable, the proceeds of which are being used to refinance the company’s existing […]
CONNECT
